Home › Hip Injuries and Disorders › NCT03181048

Clinical Trial of Concomitant Hip Arthroscopy During PAO

Single-Blind Randomized Clinical Trial of Concomitant Hip Arthroscopy During Periacetabular Osteotomy for the Management of Hip Dysplasia

Who can join

Ages 15 to 55 · All sexes

Inclusion Criteria:

* Diagnosis of hip dysplasia (DDH) electing periacetabular osteotomy (PAO) for treatment
* Skeletally mature
* Age 15 - 55
* Tonnis Grade 0 or 1 osteoarthritis (minimal or no arthritis)
* Ability to receive a standard of care preoperative (magnetic resonance imaging) MRI arthrogram of the hip

Exclusion Criteria:

* Pregnant women
* Previous surgery about the hip
* Patients receiving PAO for acetabular retroversion in the absence of DDH
* Previous hip arthroscopy to address intra-articular pathology

About the study

The study will assess the outcomes of patients treated with concomitant hip arthroscopy at the time of periacetabular osteotomy (PAO) for patients with hip dysplasia compared with patients treated with PAO alone.

What is being tested

• Periacetabular osteotomy (procedure)
• Periacetabular osteotomy with hip arthroscopy (procedure)

Sponsor: Mayo Clinic · Participants: 106 · Started: Aug 23, 2017

Contact the study team

• Cody Wyles, MD · Phone: (507) 284-1175
• Lauren Cole · Phone: 507-266-1227

Official record on ClinicalTrials.gov — NCT03181048

Locations in the U.S.

Conditions

• Hip Injuries and Disorders

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.